(692a) The Age of Application in Bioprinting | AIChE

(692a) The Age of Application in Bioprinting

Authors 

Ricky Solorzano is the CEO of Allevi, a Philadelphia-based startup that is revolutionizing biological research by building tools to make it easier to engineer biology. Allevi is specifically beginning by creating premier bioprinters that can print living tissues.

Ricky continues to lead the development of next generation products that allows scientist to design and prototype tissues. Ricky is a member of the Organ Bioengineering Scientific Direction Team for the International Space Station as well as a member on the Advanced Regenerative Manufacturing Institute.

Ricky will speak about some state of the art topics in creating tissues through bioprinting and what the future holds for biomanufacturing. In an era where bioprinting continues to hold promise sometimes its hard to understand why and how are they useful. What key applications will allow me to take my research to the next level and stay on the cutting edge. Come and listen to the key ways bioprinting is being most commonly used by researchers around the world.